InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,904.00
(
0.56%
)
Dow Jones
40,000.90
(
0.00%
)
Brent Oil
84.48
(
-0.14%
)
Bitcoin
62,561.03
(
2.93%
)
Post# of 252595
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 45
Posts 4605
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 243587

Thursday, 08/25/2022 6:15:35 PM

Thursday, August 25, 2022 6:15:35 PM

Post# of 252595
This is in line w the JNJ data from a pretty large phase 2 that showed 80 percent efficacy for severe disease and 70 for milder lower respiratory tract disease.
Gsk never gave a point estimate except to say their data is “exceptional”. I don’t know if it’s still exceptional in light of the PFE data
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up